Navnath S. Gavande

Assistant Professor

Albany College of Pharmacy and Health Sciences

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Navnath S. Gavande is an Assistant Professor at the Eugene Applebaum College of Pharmacy and Health Sciences in the United States. His research primarily focuses on cancer therapy, particularly the development of targeted drug delivery systems and innovative therapeutic approaches, as highlighted in his recent articles. His work includes significant advancements in the design of inhibitors for specific cancer-related targets and the application of nanomedicine in overcoming treatment challenges.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

John J Turchi

Indiana University School of Medicine

UNITED STATES

View details

Pamela L. Mendoza-Munoz

Assistant Research Professor of Medicine

Indiana University School of Medicine

UNITED STATES

View details

Yubin Ge

Wayne State University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Navnath S. Gavande

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Design, synthesis, and structure–activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitors

Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects

Enhanced safety and efficacy profile of CD40 antibody upon encapsulation in pHe-triggered membrane-adhesive nanoliposomes

Evolution of structure-guided drug design strategies targeting mutations in codon 12 of KRAS

An overview of the development of pharmacotherapeutics targeting SARS-CoV-2

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy

In Vivo Targeting Replication Protein A for Cancer Therapy

Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancer

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition

Collaborators (3)

John J Turchi

Pamela L. Mendoza-Munoz

Yubin Ge

Make your next move.